- Home
- APLM vs FTFT Comparison
APLM vs FTFT Comparison
Compare APLM & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- FTFT
- Stock Information
- Founded
- APLM 2016
- FTFT N/A
- Country
- APLM United States
- FTFT United States
- Employees
- APLM N/A
- FTFT N/A
- Industry
- APLM Blank Checks
- FTFT Business Services
- Sector
- APLM Finance
- FTFT Consumer Discretionary
- Exchange
- APLM Nasdaq
- FTFT Nasdaq
- Market Cap
- APLM 6.9M
- FTFT 5.9M
- IPO Year
- APLM N/A
- FTFT N/A
- Fundamental
- Price
- APLM $6.14
- FTFT $1.25
- Analyst Decision
- APLM
- FTFT
- Analyst Count
- APLM 0
- FTFT 0
- Target Price
- APLM N/A
- FTFT N/A
- AVG Volume (30 Days)
- APLM 7.8K
- FTFT 43.1K
- Earning Date
- APLM 08-13-2025
- FTFT 08-18-2025
- Dividend Yield
- APLM N/A
- FTFT N/A
- EPS Growth
- APLM N/A
- FTFT N/A
- EPS
- APLM N/A
- FTFT N/A
- Revenue
- APLM $198,000.00
- FTFT $2,031,913.00
- Revenue This Year
- APLM $415.15
- FTFT N/A
- Revenue Next Year
- APLM N/A
- FTFT N/A
- P/E Ratio
- APLM N/A
- FTFT N/A
- Revenue Growth
- APLM N/A
- FTFT N/A
- 52 Week Low
- APLM $4.47
- FTFT $1.01
- 52 Week High
- APLM $35.98
- FTFT $5.70
- Technical
- Relative Strength Index (RSI)
- APLM 47.85
- FTFT 49.94
- Support Level
- APLM $6.21
- FTFT $1.01
- Resistance Level
- APLM $6.80
- FTFT $1.16
- Average True Range (ATR)
- APLM 0.52
- FTFT 0.09
- MACD
- APLM 0.00
- FTFT 0.03
- Stochastic Oscillator
- APLM 51.61
- FTFT 87.50
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.